Among adolescents and young adults, cTnI levels remain within normal ranges after mRNA-1273 vaccination, with no evidence of increased myocardial injury.

Investigators sought to determine the long-term effects of COVID-19 infection and vaccination in patients with solid malignancies.

Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

Sanofi today announces it has become the market authorization holder in Canada for Nuvaxovid, a non-mRNA protein-based ...

Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.

WASHINGTON, April 13 (Reuters) - The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

mRNA vaccines stopped the COVID-19 pandemic in its tracks. Now, they're poised to help us against the flu, rabies, cancer, ...

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...